17.14 (-%)
As of Oct 31, 2024
Source:
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines which engage intracellular targets that have long been considered inaccessible.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | ( 857 ) 520-9158 |
| Industry | manufacturing |
| CEO | Dipal Doshi |
| Website | www.entradatx.com |